Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > SBHMY SINO BIOPHARMACEUT > Company Profile
SBHMY SINO BIOPHARMACEUT
11.665
+0.355+3.14%
Symbol
SBHMY
Company Name
SINO BIOPHARMACEUT
Listing Date
12/08/2003
Establishment Date
2000
CEO
Mr. Yi Li
Market
Pink Market
Employees
25579
Securities Type
DR
ADS Ratio
1.0 : 20.0
Fiscal Year Ends
12-31
Address
Unit 09, 41st Floor, Office Tower,Convention Plaza,1 Harbour Road, Wanchai
City
Hong Kong,China
Province
HK
Country
China
Phone
852-2802-9886
Profile
Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. It operates through the following business segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The Modernised Chinese Medicines and Chemical Medicines segment comprises the manufacturing, selling, and distribution of modernized Chinese medicine products and western medicine products. The Investment segment offers long term investments. The Other segment includes a research and development sector, which provides services to third-parties; and related healthcare and hospital business. It also develops medicines for treating tumors, analgesia, diabetes, and respiratory system diseases. The company was founded by Ping Tse on February 2, 2000 and is headquartered in Hong Kong.
Company Overview
Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. It operates through the following business segments: Modernised Chinese Medicines and Chemical Medicines, Investment, and Others. The Modernised Chinese Medicines and Chemical Medicines segment comprises the manufacturing, selling, and distribution of modernized Chinese medicine products and western medicine products. The Investment segment offers long term investments. The Other segment includes a research and development sector, which provides services to third-parties; and related healthcare and hospital business. It also develops medicines for treating tumors, analgesia, diabetes, and respiratory system diseases. The company was founded by Ping Tse on February 2, 2000 and is headquartered in Hong Kong.
CEO: Mr. Yi Li
Market: Pink Market
Listing Date: 12/08/2003
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist